UBC Okanagan leads worldwide diabetes analysis staff


A UBC Okanagan professor has been named to lead a team of 13 that recently received a $ 1 million “internationally competitive” award for accelerating diabetes research.

The team was formed through a partnership between the Canadian Institute for Health and the UK Medical Research Council.

They have launched the new MOTIVATE-TD2, a program that connects diabetes patients online with specialist health workers and helps patients exercise regularly in their own home.

Continue reading:

Coronavirus – Okanagan post-secondary students are optimistic about returning to campus

“Being physically active and exercising is critical to managing type 2 diabetes,” said Dr. Ali McManus, Professor of Health and Exercise Science at UBCO.

“Exercise helps people with diabetes control their blood sugar and reduce other serious health risks associated with the condition.”

The story continues under the advertisement

Participants with type 2 diabetes will receive cloud-connected heart rate monitors and receive tailored feedback from an exercise specialist so that, according to the university, they can start training and stick with it for a period of one year.

Continue reading:

UBC Okanagan’s drug control program aims to save lives during an overdose crisis

“Because the exercise is done at home and the counseling is virtual, the Kelowna team is recruiting participants from across Canada for this research study,” the staff wrote in a press release.

McManus said the team will work together to accelerate diabetes research and improve the lives of people with diabetes in Canada and the UK

2.16 million new cases of diabetes are expected in Canada by 2022, leading to projected health care costs of $ 15.36 billion related to treating the disease, according to the university.

2:36Okanagan students learn about culture through art-based school collaboration

Okanagan students learn about culture through art-based school collaboration

Similar news

© 2021 Global News, a division of Corus Entertainment Inc.